Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors, particularly their impact on heart health in patients with comorbidities such as type 2 diabetes and heart failure. The primary objective is to evaluate the mechanisms and effectiveness of these inhibitors in improving cardiovascular outcomes. Methods. A comprehensive review of relevant literature was conducted, focusing on recent studies, including clinical trials and meta-analyses, to assess the impact of NGLT-2 inhibitors on heart failure, diabetes, and associated cardiovascular events. The review examines various approaches related to the use of NGLT-2 inhibitors in treating cardiovascular conditions. Key Content and Findings. NGLT-2 inhibitors have been shown to significantly reduce the risk of cardiovascular events, including heart failure hospitalizations and mortality. Their mechanisms of action include improving glucose control, reducing kidney burden, and mitigating endothelial dysfunction. The review highlights these mechanisms and the clinical benefits in treating patients with heart failure and type 2 diabetes. Conclusion. NGLT-2 inhibitors represent a valuable treatment option for improving heart health in patients with type 2 diabetes and heart failure. Further research is needed to optimize their use and fully understand their underlying mechanisms.
| Mualliflar | Тригулова , Р, Мухтарова, Ш, Насырова , Х, Mukhtarova, SHakhnoza, Trigulova, Raisa, Nasirova , Khurshida, Mukhtarova, SHakhnoza, Trigulova, Raisa, Nasirova , Xurshida |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-03-30 |
| Jild | 1 |
| Son | 1 |
| Betlar | 77-82 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00010 |
DOI: 10.70626/cardiouz-2024-1-00010 · Maqolaning asl sahifasi
NGLT-2 inhibitors, cardioprotection, heart failure, type 2 diabetes, cardiovascular risk, metabolic modulation, heart function, anti-inflammatory effects, ингибиторы НГЛТ-2, кардиопротекция, сердечная недостаточность, диабет 2 типа, кардиоваскулярный риск, метаболическая модуляция, функция сердца, противовоспа- лительные эффекты, NGLT-2 ingibitorlari, kardioprotektsiya, yurak yetishmovchiligi, 2-tur diabet, yurak-qon tomir xavfi, metabolik modulyatsiya, yurak funksiyasi, yallig‘lanishga qarshi ta’sirlar
Background. To study the characteristics of the clinical course of arterial hypertension by gender in the population of the Aral Sea region and to strengthen effective preventive measures. Materials and methods. The…
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations…
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Coronary artery disease (CAD) accounts for one third of all deaths from the diseases of the…
The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic…
Background. Postoperative atrial fibrillation (POAF) is a common complication in patients undergoing coronary artery bypass grafting (CABG), which significantly affects recovery and increases the risk of adverse…
Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and…
Background.Reperfusion therapies, including primary percutaneous coronary intervention (PCI), thrombolysis, and salvage PCI, are crucial for treating patients with ST-segment elevation myocardial infarction (STEMI)…
Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased…
Background. Uncontrolled arterial hypertension in patients at high and very high cardiovascular risk remains a significant issue in modern medicine. Optimizing antihypertensive therapy using fixed or separate…
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…